Sionna Therapeutics, Inc. Common Stock (SION)
Healthcare
Biotechnology
—
49.30 $
+4.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Sionna Therapeutics, Inc. Common Stock (SION) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -66 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -36 | -44 | -53 | -66 | |
| 0.1 | 0.6 | 0.7 | -3.1 | |
| 1.7 | 2.3 | 3.7 | 12 | |
| 2.8 | -0.8 | -3.1 | -2.7 | |
| 1.9 | 1.1 | 0.0 | 0.4 | |
| -29 | 27 | -127 | -119 | |
| 111 | 0.0 | 179 | 206 | |
| 46 | -16 | -0.7 | 21 | |
| -38 | -45 | -53 | -67 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.